// App-Quantinova.ai

669 : Outcome of Treatment for Relapsed Acute Lymphoblastic Leukemia in Children with Down Syndrome

Researchers

Presenter

  • Fabian Baumann

Principal Investigators

  • Gabriele Escherich

  • Johann K. Hitzler

  • Georg Mann

  • Thomas Klingebiel

  • Andreas E Kulozik

  • Claudia Rossig

  • Martin Schrappe

  • Guenter Henze

  • Arend von Stackelberg

  • Johann K. Hitzler

Medical Centers

  • Paediatric Oncology and Hematology Charite, University Hospital Berlin, Berlin, Germany

  • Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Department of Pediatric Oncology, Hematology and Immunology,, University of Heidelberg, Heidelberg, Germany

  • Department of Medicine, University Medical Center Schleswig-Holstein, Kiel, Germany

  • Childrens Cancer Research Institute, St. Anna Kinderspital, Vienna, Austria

  • Hospital for Sick Children, Toronto, ON, Canada

  • Pediatric Hematology and Oncology, Goethe-University of Frankfurt, Frankfurt/M, Germany

Locations

  • Germany

  • Canada

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Down syndrome

Biomarkers

  • ETV6-RUNX1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved